Overview

Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults

Status:
Not yet recruiting

Trial end date:
2023-07-02

Target enrollment:

Participant gender:

Summary

A clinical trial to compare and evaluate the safety and pharmacokinetics of CKD-378

Phase:

Phase 1

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical